Cyto-Stat Trichrome CD8-Fitc/CD4-Rdi/CD3-PC5 Monoclonal Antibody Reagent with Cyto-Stat Trichrome Msiggi-Fitc/Msiggi-RD1
510(k) K964618
Active
Valid until
Not listed
FDA recalls
None foundTrust
Unverified
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | FDA 510(k)SESE 510(k) | NumberK964618 | Date23 Dec 1996 | StatusActive |
| European Union | CE/IVDD EUDAMED | Number— | Date— | StatusActive |
Recalls
No FDA recalls found in the data synced 22 Oct 2026.
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
- European Union
- United States
Specification
- 510(k) Number
- FDA Product Code
- GKZ
- Device Class
- Class II
- Regulation
- 21 CFR Part 864.5220
- Advisory Committee
- Hematology
- FDA Decision
- SESE Substantially Equivalent
Overview
AI-generated summary, 18 Sep 2026
This device is a three-color fluorescent reagent for flow cytometry, designed for the simultaneous identification and enumeration of specific lymphocyte subsets. It comprises three murine monoclonal antibodies—CD8-FITC, CD4-RD1, and CD3-PC5—each conjugated with distinct fluorochromes to enable multi-parametric analysis of CD3+, CD4+, and CD8+ cells, as well as dual-positive populations (CD3+/CD4+ and CD3+/CD8+).
The reagent is supplied as a ready-to-use solution for direct immunofluorescent staining in hematological flow cytometry applications. It is intended for single-use and requires no additional preparation beyond dilution as specified in the accompanying instructions. Authorized under FDA 510(k) clearance (K964618) and classified as an In Vitro Diagnostic Device (IVDD), it adheres to regulatory standards for medical specialty use in hematology. Storage and handling follow standard laboratory protocols for fluorescent reagents.
Other devices from Coulter Corp.
Questions
AI-generated answers, 18 Sep 2026
What specific cell types can this reagent identify and count simultaneously in a flow cytometry analysis?
This reagent is designed for the simultaneous identification and enumeration of CD3+, CD4+, and CD8+ lymphocyte subsets, as well as dual-positive populations (CD3+/CD4+ and CD3+/CD8+). The three conjugated monoclonal antibodies—CD8-FITC, CD4-RD1, and CD3-PC5—enable multi-parametric analysis to distinguish these cell types in hematological samples.
Is this reagent intended for reuse, or is it meant to be used only once per sample?
The reagent is explicitly labeled for single-use only, requiring no additional preparation beyond the specified dilution in the instructions. This ensures optimal performance and sterility for each flow cytometry analysis.
How should this reagent be stored, and are there any special handling requirements?
Storage follows standard laboratory protocols for fluorescent reagents. While the data does not specify exact conditions, typical guidelines for such reagents include refrigeration (2–8°C) and protection from light to preserve fluorochrome integrity. Always refer to the accompanying instructions for precise storage details.
What regulatory pathways does this device follow, and what medical specialty is it authorized for?
The reagent is authorized under FDA 510(k) clearance (K964618) and classified as an In Vitro Diagnostic Device (IVDD). It adheres to regulatory standards for hematology, as indicated by its advisory committee classification (HE) and medical specialty designation.
Does this reagent require any dilution or preparation before use in flow cytometry?
No additional preparation is required beyond dilution as specified in the accompanying instructions. The reagent is supplied as a ready-to-use solution, simplifying workflow for direct immunofluorescent staining in hematological flow cytometry applications.